September 7, 2021
Now available SAPHNELO™
SAPHNELO (anifrolumab-fnia) is indicated for the treatment of adult patients with moderate to severe systemic lupus erythematosus (SLE), who are receiving standard therapy.
Independence Day schedule
We will be closed on Friday, July 3 in observance of the Independence Day holiday. Delivery operations may vary across our network. We encourage you to review our full holiday schedule for more detailed information and to plan your orders accordingly.